In US, Market Exclusivity For NDI Notifications ‘Just Not There’ In DSHEA Regulation

Unfounded expectation some firms have for FDA to protect their investments in preparing successful NDI notifications is part of industry’s overall interest in increased regulation of the market, says Steven Tave, Office of Dietary Supplement Programs director.

Magnifying glass-FDA_418713547_1200.jpg

Dietary supplement marketers don’t have support in the US law that established the Food and Drug Administration’s regulatory framework for oversight of the industry to claim market exclusivity for new dietary ingredients, says the agency’s head of enforcement for the market.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation